B. Emmerich

974 total citations
39 papers, 733 citations indexed

About

B. Emmerich is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, B. Emmerich has authored 39 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 16 papers in Immunology and 14 papers in Genetics. Recurrent topics in B. Emmerich's work include Chronic Lymphocytic Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (11 papers) and Multiple Myeloma Research and Treatments (10 papers). B. Emmerich is often cited by papers focused on Chronic Lymphocytic Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (11 papers) and Multiple Myeloma Research and Treatments (10 papers). B. Emmerich collaborates with scholars based in Germany, Italy and Switzerland. B. Emmerich's co-authors include Michael Hallek, Markus Warmuth, S. Danhauser-Riedl, Brian Druker, Oliver Manzke, Heribert Bohlen, Volker Diehl, Olaf Christensen, Hans Tesch and Jürgen Wolf and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

B. Emmerich

37 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Emmerich Germany 14 360 286 254 220 183 39 733
JU Gutterman United States 11 581 1.6× 207 0.7× 152 0.6× 337 1.5× 243 1.3× 23 876
Chun Qiao China 15 353 1.0× 224 0.8× 318 1.3× 322 1.5× 159 0.9× 100 825
Hiroyuki Takahira Japan 15 305 0.8× 197 0.7× 203 0.8× 134 0.6× 169 0.9× 40 643
Anna Jankowska United States 15 494 1.4× 188 0.7× 390 1.5× 324 1.5× 185 1.0× 27 939
Ugo Consoli Italy 17 257 0.7× 239 0.8× 367 1.4× 181 0.8× 395 2.2× 36 863
D Samson United Kingdom 14 549 1.5× 169 0.6× 213 0.8× 108 0.5× 196 1.1× 23 684
Eri Kawata Japan 14 455 1.3× 134 0.5× 279 1.1× 327 1.5× 188 1.0× 42 842
R. Fischer Germany 15 365 1.0× 104 0.4× 166 0.7× 341 1.6× 136 0.7× 41 741
Guillermo Martín–Núñez Spain 13 572 1.6× 168 0.6× 416 1.6× 289 1.3× 248 1.4× 26 822
Anand Jillella United States 12 379 1.1× 136 0.5× 456 1.8× 113 0.5× 166 0.9× 48 841

Countries citing papers authored by B. Emmerich

Since Specialization
Citations

This map shows the geographic impact of B. Emmerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Emmerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Emmerich more than expected).

Fields of papers citing papers by B. Emmerich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Emmerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Emmerich. The network helps show where B. Emmerich may publish in the future.

Co-authorship network of co-authors of B. Emmerich

This figure shows the co-authorship network connecting the top 25 collaborators of B. Emmerich. A scholar is included among the top collaborators of B. Emmerich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Emmerich. B. Emmerich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Eichhorst, Barbara, Raymonde Busch, Carmen D. Schweighofer, et al.. (2006). Due to low infection rates no routine anti‐infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine‐based first line therapy. British Journal of Haematology. 136(1). 63–72. 21 indexed citations
4.
Busch, Robert, et al.. (2005). Fludarabine plus cyclophosphamide (FC) induces higher remission rates and longer progression free survival (PFS) than fludarabine (F) alone in first line therapy of younger patients (PTS) with chronic lymphocytic leukemia (CLL): Results of a phase III stu. mediaTUM (Technical University of Munich). 89–90. 1 indexed citations
5.
Folwaczny, C, et al.. (2002). Ulcerative Colitis in a Patient with Wiskott-Aldrich Syndrome. Endoscopy. 34(10). 840–841. 21 indexed citations
6.
Mitterer, Manfred, Mirija Svaldi, Fuat Oduncu, et al.. (2001). Peripheral Blood Monoclonal B-Cells Predict the Event Free Survival in Multiple Myeloma. Leukemia & lymphoma. 41(3-4). 387–395. 9 indexed citations
7.
Hallek, Michael, et al.. (2001). Chronic lymphocytic leukemia - Part 2: Treatment. DMW - Deutsche Medizinische Wochenschrift. 126(23). 690–695. 1 indexed citations
8.
Christensen, Olaf, Oliver Manzke, Hans Tesch, et al.. (2000). Vaccination of multiple myeloma patients with idiotype‐pulsed dendritic cells: immunological and clinical aspects. British Journal of Haematology. 108(4). 805–816. 168 indexed citations
9.
Gahn, B., G. Brittinger, Gottfried Dölken, et al.. (2000). Multicenter Phase II Study of Oral Idarubicin in Treated and Untreated Patients with B-Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 37(1-2). 169–173. 2 indexed citations
10.
Mitterer, Manfred, Fuat Oduncu, P Fabris, et al.. (1999). The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients. British Journal of Haematology. 106(3). 737–743. 26 indexed citations
11.
12.
Liebl, Bernhard, et al.. (1997). Defects of β2‐adrenergic signal transduction in chronic lymphocytic leukaemia: relationship to disease progression. European Journal of Clinical Investigation. 27(2). 121–127. 11 indexed citations
13.
Dengler, Robert, et al.. (1995). Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.. PubMed. 1(2). 199–205. 2 indexed citations
14.
Gerhartz, H, M. Engelhard, G. Brittinger, et al.. (1994). Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.. PubMed. 21(6 Suppl 16). 25–8. 5 indexed citations
15.
Emmerich, B., et al.. (1992). Influence of OM-85 BV on Different Humoral and Cellular Immune Defense Mechanisms of the Respiratory Tract. Respiration. 59(3). 19–23. 19 indexed citations
16.
Flieger, Dimitri, B. Emmerich, Nicolette Meyer, Gert Riethmüller, & H. W. Löms Ziegler‐Heitbrock. (1990). Deficient production of tumor necrosis factor by peripheral‐blood monocytes in chronic lymphocytic leukemia. International Journal of Cancer. 45(2). 280–286. 13 indexed citations
17.
Schlag, Rudolf, Dimitri Flieger, HW Ziegler-Heitbrock, et al.. (1990). Interferon α-2b bei chronischer lymphatischer Leukämie vom B-Zell-Typ*. DMW - Deutsche Medizinische Wochenschrift. 115(28/29). 1088–1095. 1 indexed citations
18.
Maubach, P., M. Bauchinger, B. Emmerich, & Johann Rastetter. (1985). Trisomy 7 and 8 in Ph-negative chronic eosinophilic leukemia. Cancer Genetics and Cytogenetics. 17(2). 159–164. 9 indexed citations
19.
Siegert, W., H. Theml, U. Fink, et al.. (1983). Treatment of non-hodgkin's lymphoma of low-grade malignancy with human fibroblast interferon.. PubMed. 2(4). 193–8. 12 indexed citations
20.
Berdel, Wolfgang E., U. Fink, B. Emmerich, et al.. (1982). Early tumor and leukemia response to alkyl-lysophospholipids in a phase I study. Cancer. 50(10). 2011–2015. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JU Gutterman Breakdown of academic impact, for papers by Chun Qiao Breakdown of academic impact, for papers by Hiroyuki Takahira Breakdown of academic impact, for papers by Anna Jankowska Breakdown of academic impact, for papers by Ugo Consoli Breakdown of academic impact, for papers by D Samson Breakdown of academic impact, for papers by Eri Kawata Breakdown of academic impact, for papers by R. Fischer Breakdown of academic impact, for papers by Guillermo Martín–Núñez Breakdown of academic impact, for papers by Anand Jillella
Rankless by CCL
2026